Yonsei Research Leads to Change in Lung Cancer Treatment Worldwide

SEOUL, Dec. 28 (Korea Bizwire) – A South Korean medical research team’s treatment of patients diagnosed with ROS1 gene rearrangement non-small lung cancer with the drug Ceritinib has led to a change in globally accepted treatment methods. From June 2013 through February 2016, Yonsei Cancer Center researchers conducted drug therapies on 404 stage 4 lung [...]